Peritoneal adhesion prevention with a biodegradable and injectable N,O-carboxymethyl chitosan-aldehyde hyaluronic acid hydrogel in a rat repeated-injury model

Sci Rep. 2016 Nov 21:6:37600. doi: 10.1038/srep37600.

Abstract

Postoperative peritoneal adhesion is one of the serious issues because it induces severe clinical disorders. In this study, we prepared biodegradable and injectable hydrogel composed of N,O-carboxymethyl chitosan (NOCC) and aldehyde hyaluronic acid (AHA), and assessed its anti-adhesion effect in a rigorous and severe recurrent adhesion model which is closer to clinical conditions. The flexible hydrogel, which gelated in 66 seconds at 37 °C, was cross-linked by the schiff base derived from the amino groups of NOCC and aldehyde groups in AHA. In vitro cytotoxicity test showed the hydrogel was non-toxic. In vitro and in vivo degradation examinations demonstrated the biodegradable and biocompatibility properties of the hydrogel. The hydrogel discs could prevent the invasion of fibroblasts, whereas fibroblasts encapsulated in the porous 3-dimensional hydrogels could grow and proliferate well. Furthermore, the hydrogel was applied to evaluate the anti-adhesion efficacy in a more rigorous recurrent adhesion model. Compared with normal saline group and commercial hyaluronic acid (HA) hydrogel, the NOCC-AHA hydrogel exhibited significant reduction of peritoneal adhesion. Compared to control group, the blood and abdominal lavage level of tPA was increased in NOCC-AHA hydrogel group. These findings suggested that NOCC-AHA hydrogel had a great potential to serve as an anti-adhesion candidate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biocompatible Materials / chemistry
  • Biocompatible Materials / pharmacology
  • Biocompatible Materials / therapeutic use*
  • Cell Death
  • Cell Survival
  • Chitosan / chemistry
  • Chitosan / pharmacology
  • Chitosan / therapeutic use*
  • Disease Models, Animal
  • Fibroblasts / drug effects
  • Fibroblasts / pathology
  • Hyaluronic Acid / chemistry
  • Hyaluronic Acid / pharmacology
  • Hyaluronic Acid / therapeutic use*
  • Hydrogel, Polyethylene Glycol Dimethacrylate / chemistry
  • Hydrogel, Polyethylene Glycol Dimethacrylate / pharmacology
  • Hydrogel, Polyethylene Glycol Dimethacrylate / therapeutic use*
  • Injections*
  • Male
  • Mice
  • NIH 3T3 Cells
  • Oxidation-Reduction
  • Peritoneum / pathology*
  • Peritoneum / ultrastructure
  • Plasminogen Activator Inhibitor 1 / blood
  • Rats
  • Rats, Sprague-Dawley
  • Rheology
  • Tissue Adhesions / blood
  • Tissue Adhesions / drug therapy
  • Tissue Adhesions / prevention & control*
  • Tissue Plasminogen Activator / blood

Substances

  • Biocompatible Materials
  • Plasminogen Activator Inhibitor 1
  • O,N-carboxymethylchitosan
  • Hydrogel, Polyethylene Glycol Dimethacrylate
  • Hyaluronic Acid
  • Chitosan
  • Tissue Plasminogen Activator